132 related articles for article (PubMed ID: 30998296)
1. Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single-Cell Clone-Forming Inhibition Assay.
Lin D; Li P; Feng J; Lin Z; Chen X; Yang N; Wang L; Liu D
Small; 2020 Mar; 16(9):e1901001. PubMed ID: 30998296
[TBL] [Abstract][Full Text] [Related]
2. Microgel Single-Cell Culture Arrays on a Microfluidic Chip for Selective Expansion and Recovery of Colorectal Cancer Stem Cells.
Lin D; Chen X; Liu Y; Lin Z; Luo Y; Fu M; Yang N; Liu D; Cao J
Anal Chem; 2021 Sep; 93(37):12628-12638. PubMed ID: 34495647
[TBL] [Abstract][Full Text] [Related]
3. Gel-Free Single-Cell Culture Arrays on a Microfluidic Chip for Highly Efficient Expansion and Recovery of Colon Cancer Stem Cells.
Liu Y; Chen X; Chen J; Luo Y; Chen Z; Lin D; Zhang J; Liu D
ACS Biomater Sci Eng; 2022 Aug; 8(8):3623-3632. PubMed ID: 35786837
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target.
Zhang F; Rothermund K; Gangadharan SB; Pommier Y; Prochownik EV; Lazo JS
Oncotarget; 2012 Sep; 3(9):998-1010. PubMed ID: 22948175
[TBL] [Abstract][Full Text] [Related]
5. Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing.
Wang X; He T; Chen Z; Chen J; Luo Y; Lin D; Li X; Liu D
Lab Chip; 2024 Mar; 24(6):1702-1714. PubMed ID: 38321884
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anticancer agents using flow cytometry analysis of cancer stem cells.
Gupta V; Zhang QJ; Liu YY
Methods Mol Biol; 2011; 716():179-91. PubMed ID: 21318907
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
[TBL] [Abstract][Full Text] [Related]
8. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
[TBL] [Abstract][Full Text] [Related]
9. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
[TBL] [Abstract][Full Text] [Related]
10. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
11. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Moriya T
Breast Cancer; 2016 May; 23(3):425-36. PubMed ID: 25552385
[TBL] [Abstract][Full Text] [Related]
13. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
14. Targeting Breast Cancer Stem Cells: A Methodological Perspective.
Velasco-Velázquez MA; Velázquez-Quesada I; Vásquez-Bochm LX; Pérez-Tapia SM
Curr Stem Cell Res Ther; 2019; 14(5):389-397. PubMed ID: 30147014
[TBL] [Abstract][Full Text] [Related]
15. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
16. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells.
Sun R; Shen S; Zhang YJ; Xu CF; Cao ZT; Wen LP; Wang J
Biomaterials; 2016 Oct; 103():44-55. PubMed ID: 27376558
[TBL] [Abstract][Full Text] [Related]
19. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
Vásquez-Bochm LX; Velázquez-Paniagua M; Castro-Vázquez SS; Guerrero-Rodríguez SL; Mondragon-Peralta A; De La Fuente-Granada M; Pérez-Tapia SM; González-Arenas A; Velasco-Velázquez MA
Pharmacol Rep; 2019 Jun; 71(3):535-544. PubMed ID: 31026757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
